RxDoctor Payments Data

Catherine Konyn

Adult Health · Escondido, CANPI 1437488160

Payments from drug & device makers

$191in general payments, 2019–2025

Across 10 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$35
  • Viiv Healthcare Company$34
  • Redhill Biopharma Inc.$29
  • Corcept Therapeutics$23
  • Dexcom, Inc.$22
  • Lilly USA, LLC$19
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$191100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$191 in reported general payments places this provider in the 35th percentile of 785 adult health providers in California.

See all adult health providers in California

Medicare billing

Part B allowed, 2024
$39,275
Medicare patients
183
Services billed
414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$19,859
OzempicSemaglutide18$16,296
Combivent RespimatIpratropium/Albuterol Sulfate28$12,910
XareltoRivaroxaban11$9,630
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,131
LinzessLinaclotide11$6,788
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$2,067
Potassium Chloride18$1,360
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$983
Atorvastatin Calcium94$763
Albuterol Sulfate HfaAlbuterol Sulfate28$532
Tamsulosin Hcl27$478
Bumetanide11$425
Fluticasone Propionate26$292
Gabapentin16$277

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$35$16,29618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 785 adult health providers in California.

Other adult health in Escondido

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →